Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Refractory Solid Tumors 1

Interventions

Cisplatin 2spartalizumab 1lavender oil 1jojoba wax 1eltrombopag 1decitabine and cedazuridine drug combination 1Ultrasonography, Doppler 1Ultrasonography 1Specimen Handling 1Sorafenib 1Positron-Emission Tomography 1Paclitaxel 1P7170 compound 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Injections 1Ifosfamide 1Fluorodeoxyglucose F18 1Everolimus 1Etoposide 1Docetaxel 1Carboplatin 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × P7170 compound × Other solid neoplasm × Clear all
NCT01762410 2014-09-29

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Piramal Enterprises Limited

Phase 1 Suspended
60 enrolled
Other solid neoplasm

Advanced Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡